1.22

3.39% 0.04

Petmed Express Inc (PETS)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Petmed Express Inc stock is traded at $1.22, with a volume of 271.95K. It is up +3.39% in the last 24 hours and down -21.29% over the past month. PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.

Previous Close:

$1.18

Open:

$1.17

24h Volume:

271.95K

Relative Volume:

1.93

Market Cap:

$26.45M

Revenue:

$179.02M

Net Income/Loss:

$-57.29M

P/E Ratio:

-0.4438

EPS:

-2.7487

Net Cash Flow:

$-33.01M

1W Performance:

+3.39%

1M Performance:

-21.29%

6M Performance:

-45.29%

1Y Performance:

-55.64%

1-Day Range:

$1.1699

$1.2651

1-Week Range:

$1.15

$1.2651

52-Week Range:

$1.15

$4.10

Petmed Express Inc Stock (PETS) Company Profile

Name

Petmed Express Inc

Sector

Healthcare (1052)

Industry

Pharmaceutical Retailers (5)

Phone

(561) 426-4444

Address

420 SOUTH CONGRESS AVENUE, DELRAY BEACH

Employee

189

Twitter

@1800petmeds

Next Earnings Date

null

Latest SEC Filings

PETS's Discussions on Twitter

Compare PETS vs HITI, SCNX, POM, RDGT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PETS Petmed Express Inc	1.22	26.45M	179.02M	-57.29M	-33.01M	-2.7487
HITI High Tide Inc	2.59	230.88M	486.49M	-33.29M	10.86M	-0.3627
SCNX Scienture Holdings Inc	2.88	4.73M	656.60K	-16.79M	-11.12M	-1.0743
POM Pomdoctor Ltd Adr	1.17	3.25M	0	0	0	0.00
RDGT Ridgetech Inc	0.801	2.91M	111.62M	762.70K	16.36M	-85.73

Petmed Express Inc Stock (PETS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-25-23	Initiated	Lake Street	Buy
Jan-20-22	Upgrade	Sidoti	Neutral → Buy
Nov-18-21	Initiated	Morgan Stanley	Underweight
Oct-01-21	Initiated	Jefferies	Hold
Aug-05-21	Resumed	Credit Suisse	Underperform
Jun-03-21	Downgrade	Sidoti	Buy → Neutral
Mar-05-21	Upgrade	Sidoti	Neutral → Buy
Jan-27-21	Downgrade	Sidoti	Buy → Neutral
Aug-19-20	Upgrade	Sidoti	Neutral → Buy
Apr-09-20	Downgrade	Sidoti	Buy → Neutral
Mar-12-20	Upgrade	Sidoti	Neutral → Buy
Feb-24-20	Downgrade	Sidoti	Buy → Neutral
Aug-16-19	Downgrade	Craig Hallum	Buy → Hold
Jun-15-18	Initiated	CL King	Neutral
Aug-24-17	Upgrade	Sidoti	Neutral → Buy
Jul-24-17	Upgrade	Northcoast	Neutral → Buy
May-09-16	Upgrade	Craig Hallum	Sell → Hold
Feb-04-16	Initiated	Credit Suisse	Underperform
Jul-19-10	Downgrade	CL King	Strong Buy → Accumulate
Jul-19-10	Reiterated	JMP Securities	Mkt Outperform
May-25-10	Downgrade	Wedbush	Neutral → Underperform
May-06-10	Reiterated	Wedbush	Neutral
Mar-23-10	Downgrade	Janney Mntgmy Scott	Buy → Neutral
Mar-18-10	Downgrade	Piper Jaffray	Overweight → Neutral
Feb-16-10	Reiterated	CL King	Strong Buy
Jul-21-09	Upgrade	Piper Jaffray	Neutral → Overweight
Jan-07-09	Initiated	CL King	Strong Buy

View All

Petmed Express Inc Stock (PETS) Latest News

Oct 20, 2026

PetMed Express stock gains 4.35 percent on Nasdaq. Morgan Stanley holds USD 1.40 target - AD HOC NEWS

Oct 20, 2026

Oct 13, 2026

PetMed Express, Inc. Actuals & Estimates (HAM:PQM) - TradingView

Oct 13, 2026

Oct 12, 2026

PetMed Express (Nasdaq:PETS)Stock Analysis - Simply Wall Street

Oct 12, 2026

Oct 08, 2026

PetMed Express appointed Tamar Elkeles and PetMed Express stock stayed unchanged - AD HOC NEWS

Oct 08, 2026

Sep 30, 2026

Cash flow from operating activities of PetMed Express, Inc. – HAN:PQM - TradingView

Sep 30, 2026

Sep 29, 2026

PetMed Express CEO Jeffrey Willard Granted 500,000 Shares in Equity Awards - Kalkine Media

Sep 29, 2026

Current ratio of PetMed Express, Inc. – HAN:PQM - TradingView

Sep 29, 2026

PetMed Express CEO Jeffrey Allen Willard Files Initial SEC Ownership Disclosure - Kalkine Media

Sep 29, 2026

A 250,000-share restricted award goes to PetMed Express (PETS) CEO. Another grant hinges on returns. - stocktitan.net

Sep 29, 2026

Jeffrey Allen Willard, CEO and president of PetMed Express (PETS), is named in an initial ownership report. - stocktitan.net

Sep 29, 2026

Sep 28, 2026

PetMed Express Files to Register 1.8 Million Additional Shares Under Updated 2024 Incentive Plan - Kalkine Media

Sep 28, 2026

PetMed names Jeffrey Allen Willard as CEO with equity grants under amended plan - TradingView

Sep 28, 2026

Sep 25, 2026

PETS Maintains Rating by Morgan Stanley -- Price Target Lowered to $1.40 - gurufocus.com

Sep 25, 2026

PetMed Express Is Maintained at Underweight by Morgan Stanley - Moomoo

Sep 25, 2026

Sep 22, 2026

Form 8K PetMed Express Inc For: 22 September By Investing.com - Investing.com Canada

Sep 22, 2026

Sep 21, 2026

PetMed Express appoints Tamar Elkeles to board of directors By Investing.com - Investing.com Nigeria

Sep 21, 2026

PetMed Express (PETS) Advances to $1.88, Holding Above Key Support in Low-Priced RangeVolume Dry Up - vinanet.vn

Aug 30, 2026

PetMed Express (PETS) Advances to $1.88, Holding Above Key Support in Low-Priced RangeEntry Point Alerts - dars.gov.et

Aug 30, 2026

Aug 28, 2026